A Randomized Phase III Trial of IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Low Dose Paclitaxel 40 mg/m2/wk Versus IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Observation in Patients With Early Stage Ovarian Carcinoma
A Randomized Phase III Trial of IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Low Dose Paclitaxel 40 mg/m2/wk Versus IV Carboplatin (AUC 6) and Paclitaxel 175 mg/m2 Q 21 Days x 3 Courses Plus Observation in Patients With Early Stage Ovarian Carcinoma
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether receiving combined carboplatin and paclitaxel plus continued low-dose paclitaxel is more effective than carboplatin and paclitaxel alone for early-stage ovarian cancer.
PURPOSE: This randomized phase III trial is studying carboplatin and paclitaxel alone too see how well they work compared to carboplatin and paclitaxel together with continued low-dose paclitaxel in treating patients with early-stage ovarian cancer.
OBJECTIVES:
OUTLINE: This is a randomized, multicenter study. Patients are randomized to 1 of 2 treatment arms.
Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study within 5.5 years.
DISEASE CHARACTERISTICS:
Histologically confirmed ovarian epithelial cancer of one of the following histologic cell types:
Meets 1 of the following criteria:
Complete surgical staging
No tumors of low malignant potential (borderline tumors)
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Other:
Birmingham, Alabama 35294, United States
Long Beach, California 90801, United States
Orange, California 92868, United States
Hartford, Connecticut 06102-5037, United States
Orlando, Florida 32803-1273, United States
Tampa, Florida 33612-9497, United States
Savannah, Georgia 31403-3089, United States
Chicago, Illinois 60611-3013, United States
La Porte, Indiana 46350, United States
Kansas City, Kansas 66160-7357, United States
Wichita, Kansas 67214, United States
Lexington, Kentucky 40536-0293, United States
Louisville, Kentucky 40202, United States
Baltimore, Maryland 21231-2410, United States
Springfield, Massachusetts 01199, United States
Saint Joseph, Michigan 49085, United States
Minneapolis, Minnesota 55455, United States
Columbia, Missouri 65203, United States
Lebanon, New Hampshire 03756-0002, United States
Marlton, New Jersey 08053, United States
Voorhees Township, New Jersey 08043, United States
Voorhees Township, New Jersey 08043, United States
Albuquerque, New Mexico 87131-5636, United States
Chapel Hill, North Carolina 27599-7295, United States
Charlotte, North Carolina 28232-2861, United States
Greensboro, North Carolina 27403-1198, United States
Greenville, North Carolina 27835-6028, United States
Pinehurst, North Carolina 28374, United States
Winston-Salem, North Carolina 27157-1096, United States
Columbus, Ohio 43210-1240, United States
Allentown, Pennsylvania 18105, United States
Hershey, Pennsylvania 17033-0850, United States
Philadelphia, Pennsylvania 19104-4283, United States
Wilkes-Barre, Pennsylvania 18711, United States
Sioux Falls, South Dakota 57117-5039, United States
Knoxville, Tennessee 37901, United States
Dallas, Texas 75390, United States
Burlington, Vermont 05401, United States
Kagoshima City, Kagoshima, 892-8580, Japan